Change in Management
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare reported strong FY2026 results with standalone revenue of Rs 13,655 Lakhs (up 12% YoY) and consolidated revenue of Rs 16,458 Lakhs (up 24% YoY). Standalone PAT grew 26% to Rs 1,575 Lakhs while consolidated PAT rose 31% to Rs 1,912 Lakhs. The Board declared a 2nd interim dividend of Rs 1 per share with record date May 19, 2026, following an earlier Rs 4 per share interim dividend. The company announced a change in statutory auditors, recommending Deloitte Haskins & Sells to replace retiring B S R & Co. LLP for 5 years subject to shareholder approval at the 26th AGM. Additionally, Dr. Nilesh Shah will transition from President - Internal Assurance to an advisory role from May 14, 2026, ceasing to be classified as Senior Management Personnel.
The company delivered robust double-digit growth in both revenue and profitability for FY2026. The departure of Dr. Nilesh Shah from Senior Management represents a notable change in key personnel. The ongoing income tax dispute (reduced demand of Rs 3,880 Lakhs) and upcoming auditor transition are key monitoring points for investors.